nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

03.01.2021 | Review – Cancer Research

MAPK signaling pathway-targeted marine compounds in cancer therapy

verfasst von: Jiaen Wei, Ruining Liu, Xiyun Hu, Tingen Liang, Zhiran Zhou, Zunnan Huang

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This paper reviews marine compounds that target the mitogen-activated protein kinase (MAPK) signaling pathway and their main sources, chemical structures, major targeted cancers and possible mechanisms to provide comprehensive and basic information for the development of marine compound-based antitumor drugs in clinical cancer therapy research.

Methods

This paper searched the PubMed database using the keywords “cancer”, “marine*” and “MAPK signaling pathway”; this search was supplemented by the literature-tracing method. The marine compounds screened for review in this paper are pure compounds with a chemical structure and have antitumor effects on more than one tumor cell line by targeting the MAPK signaling pathway. The PubChem database was used to search for the PubMed CID and draw the chemical structures of the marine compounds.

Results

A total of 128 studies were searched, and 32 marine compounds with unique structures from extensive sources were collected for this review. These compounds are cytotoxic to cancer cell lines, although their targets are still unclear. This paper describes their anticancer effect mechanisms and the protein expression changes in the MAPK pathway induced by these marine compound treatments. This review is the first to highlight MAPK signaling pathway-targeted marine compounds and their use in cancer therapy.

Conclusion

The MAPK signaling pathway is a promising potential target for cancer therapy. Searching for marine compounds that exert anticancer effects by targeting the MAPK signaling pathway and developing them into new marine anticancer drugs will be beneficial for cancer treatment.

Nur mit Berechtigung zugänglich

Ali T, Inagaki M, Chai H-B et al (2017) Halogenated compounds from directed fermentation of Penicillium concentricum, an Endophytic fungus of the liverwort Trichocolea tomentella. J Nat Prod 80(5):1397–1403. https://doi.org/10.1021/acs.jnatprod.6b01069CrossRefPubMed

Alves C, Silva J, Pinteus S et al (2018) From marine origin to therapeutics: the antitumor potential of marine algae-derived compounds. Front Pharmacol 9:777. https://doi.org/10.3389/fphar.2018.00777CrossRefPubMedPubMedCentral

Bach DH, Kim SH, Hong JY et al (2015) Salternamide A suppresses hypoxia-induced accumulation of HIF-1α and induces apoptosis in human colorectal cancer cells. Mar Drugs 13(11):6962–6976. https://doi.org/10.3390/md13116962CrossRefPubMedPubMedCentral

Bae SY, Kim GD, Jeon JE et al (2013) Anti-proliferative effect of (19Z)-halichondramide, a novel marine macrolide isolated from the sponge Chondrosia corticata, is associated with G2/M cell cycle arrest and suppression of mTOR signaling in human lung cancer cells. Toxicol In Vitro 27(2):694–699. https://doi.org/10.1016/j.tiv.2012.11.001CrossRefPubMed

Besednova NN, Zvyagintseva TN, Kuznetsova TA et al (2019) Marine algae metabolites as promising therapeutics for the prevention and treatment of HIV/AIDS. Metabolites 9(5):87. https://doi.org/10.3390/metabo9050087CrossRefPubMedCentral

Biscardi M, Caporale R, Balestri F et al (2005) VEGF inhibition and cytotoxic effect of aplidin in leukemia cell lines and cells from acute myeloid leukemia. Ann Oncol 16(10):1667–1674. https://doi.org/10.1093/annonc/mdi311CrossRefPubMed

Blunt JW, Copp BR, Hu WP et al (2007) Marine natural products. Nat Prod Rep 24(1):31–86. https://doi.org/10.1039/b603047pCrossRefPubMed

Blunt JW, Copp BR, Keyzers RA et al (2016) Marine natural products. Nat Prod Rep 33(3):382–431. https://doi.org/10.1039/c5np00156kCrossRefPubMed

Boo HJ, Hong JY, Kim SC et al (2013) The anticancer effect of fucoidan in PC-3 prostate cancer cells. Mar Drugs 11(8):2982–2999. https://doi.org/10.3390/md11082982CrossRefPubMedPubMedCentral

Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492CrossRef

Burotto M, Chiou VL, Lee JM et al (2014) The MAPK pathway across different malignancies: a new perspective. Cancer 120(22):3446–3456. https://doi.org/10.1002/cncr.28864CrossRefPubMedPubMedCentral

Chappell WH, Steelman LS, Long JM et al (2011) Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. Oncotarget 2(3):135–164. https://doi.org/10.18632/oncotarget.240CrossRefPubMedPubMedCentral

Chen F, Zhang Z, Leonard SS et al (2001) Contrasting roles of NF-kappaB and JNK in arsenite-induced p53-independent expression of GADD45alpha. Oncogene 20(27):3585–3589. https://doi.org/10.1038/sj.onc.1204442CrossRefPubMed

Chen SC, Chien YC, Pan CH et al (2014) Inhibitory effect of dihydroaustrasulfone alcohol on the migration of human non-small cell lung carcinoma A549 cells and the antitumor effect on a Lewis lung carcinoma-bearing tumor model in C57BL/6J mice. Mar Drugs 12(1):196–213. https://doi.org/10.3390/md12010196CrossRefPubMedPubMedCentral

Chikamatsu S, Saijo K, Imai H et al (2019) In Vitro and in Vivo antitumor activity and the mechanism of siphonodictyal B in human colon cancer cells. Cancer Med 8(12):5662–5672. https://doi.org/10.1002/cam4.2409CrossRefPubMedPubMedCentral

Choo GS, Lee HN, Shin SA et al (2016) Anticancer effect of fucoidan on DU-145 prostate cancer cells through inhibition of PI3K/Akt and MAPK pathway expression. Mar Drugs. https://doi.org/10.3390/md14070126CrossRefPubMedPubMedCentral

Cóbar OM, Rodríguez AD, Padilla OL et al (1997) The calyculaglycosides: dilophol-type diterpene glycosides exhibiting antiinflammatory activity from the Caribbean gorgonianEunicea sp.(1)(,)(2). J Org Chem 62(21):7183–7188. https://doi.org/10.1021/jo9704725CrossRefPubMed

Cole RJ, Kirksey JW, Dorner JW et al (1977) Mycotoxins produced by Aspergillus fumigatus species isolated from molded silage. Food Chem 25(4):826–830. https://doi.org/10.1021/jf60212a015CrossRef

Crews P, Bescansa P (1986) Sesterterpenes from a common marine sponge, Hyrtios erecta. J Nat Prod 49(6):1041–1052. https://doi.org/10.1021/np50048a012CrossRefPubMed

Cuadrado A, Nebreda AR (2010) Mechanisms and functions of p38 MAPK signalling. Biochem J 429(3):403–417. https://doi.org/10.1042/BJ20100323CrossRefPubMed

Cuadrado A, Garcia-Fernandez LF, Gonzalez L et al (2003) Aplidin induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK. J Biol Chem 278(1):241–250. https://doi.org/10.1074/jbc.M201010200CrossRefPubMed

Das SK, Hashimoto T, Kanazawa K (2008) Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D. Biochim Biophys Acta 1780(4):743–749. https://doi.org/10.1016/j.bbagen.2008.01.003CrossRefPubMed

Deacon K, Mistry P, Chernoff J et al (2003) p38 Mitogen-activated protein kinase mediates cell death and p21-activated kinase mediates cell survival during chemotherapeutic drug-induced mitotic arrest. Mol Biol Cell 14(5):2071–2087. https://doi.org/10.1091/mbc.e02-10-0653CrossRefPubMedPubMedCentral

Dehm SM, Tindall DJ (2006) Molecular regulation of androgen action in prostate cancer. J Cell Biochem 99(2):333–344. https://doi.org/10.1002/jcb.20794CrossRefPubMed

Dimberg LY, Anderson CK, Camidge R et al (2013) On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics. Oncogene 32(11):1341–1350. https://doi.org/10.1038/onc.2012.164CrossRefPubMed

Dorner JW, Cole RJ, Springer JP et al (1980) Isolation and identification of two new biologically active norditerpene dilactones from Aspergillus wentii. Phytochemistry 19(6):1157–1161. https://doi.org/10.1016/0031-9422(80)83075-5CrossRef

Dupont J, LeRoith D (2001) Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction. Horm Res 55(Suppl 2):22–26. https://doi.org/10.1159/000063469CrossRefPubMed

Durig J, Bruhn T, Zurborn KH et al (1997) Anticoagulant fucoidan fractions from Fucus vesiculosus induce platelet activation in vitro. Thromb Res 85(6):479–491. https://doi.org/10.1016/s0049-3848(97)00037-6CrossRefPubMed

Dyshlovoy SA, Honecker F (2018) Marine compounds and cancer: 2017 updates. Mar Drugs 16(2):41. https://doi.org/10.3390/md16020041CrossRefPubMedCentral

Dyshlovoy SA, Fedorov SN, Kalinovsky AI et al (2012) Mycalamide A shows cytotoxic properties and prevents EGF-induced neoplastic transformation through inhibition of nuclear factors. Mar Drugs 10(6):1212–1224. https://doi.org/10.3390/md10061212CrossRefPubMedPubMedCentral

Dyshlovoy SA, Tabakmakher KM, Hauschild J et al (2016) Guanidine alkaloids from the marine sponge monanchora pulchra show cytotoxic properties and prevent EGF-induced neoplastic transformation in vitro. Mar Drugs. https://doi.org/10.3390/md14070133CrossRefPubMedPubMedCentral

Dyshlovoy SA, Kaune M, Kriegs M et al (2020) Marine alkaloid monanchoxymycalin C: a new specific activator of JNK1/2 kinase with anticancer properties. Sci Rep 10(1):13178. https://doi.org/10.1038/s41598-020-69751-zCrossRefPubMedPubMedCentral

Elhady SS, El-Halawany AM, Alahdal AM et al (2016) A new bioactive metabolite isolated from the red sea marine sponge Hyrtios erectus. Molecules 21(1):82. https://doi.org/10.3390/molecules21010082CrossRefPubMedPubMedCentral

Erba E, Serafini M, Gaipa G et al (2003) Effect of Aplidin in acute lymphoblastic leukaemia cells. Br J Cancer 89(4):763–773. https://doi.org/10.1038/sj.bjc.6601130CrossRefPubMedPubMedCentral

García-Fernández LF, Losada A, Alcaide V et al (2002) Aplidin induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase C delta. Oncogene 21(49):7533–7544. https://doi.org/10.1038/sj.onc.1205972CrossRefPubMed

Goetz LH, Schork NJ (2018) Personalized medicine: motivation, challenges, and progress. Fertil Steril 109(6):952–963. https://doi.org/10.1016/j.fertnstert.2018.05.006CrossRefPubMedPubMedCentral

Gomes NG, Dasari R, Chandra S et al (2016) Marine Invertebrate metabolites with anticancer activities: solutions to the “supply problem.” Mar Drugs. https://doi.org/10.3390/md14050098CrossRefPubMedPubMedCentral

Gong AJ, Gong LL, Yao WC et al (2015) Aplysin induces apoptosis in glioma cells through HSP90/AKT pathway. Exp Biol Med (Maywood) 240(5):639–644. https://doi.org/10.1177/1535370214555664CrossRef

González-Santiago L, Suárez Y, Zarich N et al (2006) Aplidin induces JNK-dependent apoptosis in human breast cancer cells via alteration of glutathione homeostasis, Rac1 GTPase activation, and MKP-1 phosphatase downregulation. Cell Death Differ 13(11):1968–1981. https://doi.org/10.1038/sj.cdd.4401898CrossRefPubMed

Guo CL, Wang LJ, Zhao Y et al (2018) A novel bromophenol derivative BOS-102 induces cell cycle arrest and apoptosis in human A549 lung cancer cells via ROS-mediated PI3K/Akt and the MAPK signaling pathway. Mar Drugs. https://doi.org/10.3390/md16020043CrossRefPubMedPubMedCentral

Guo C, Wang L, Zhao Y et al (2019) BOS-93, a novel bromophenol derivative, induces apoptosis and autophagy in human A549 lung cancer cells via PI3K/Akt/mTOR and MAPK signaling pathway. Exp Ther Med 17(5):3848–3858. https://doi.org/10.3892/etm.2019.7402CrossRefPubMedPubMedCentral

Guzii AG, Makarieva TN, Denisenko VA et al (2010) Monanchocidin: a new apoptosis-inducing polycyclic guanidine alkaloid from the marine sponge Monanchora pulchra. Org Lett 12(19):4292–4295. https://doi.org/10.1021/ol101716xCrossRefPubMed

Ham J, Lim W, Kim K et al (2019) Gentisyl alcohol inhibits proliferation and induces apoptosis via mitochondrial dysfunction and regulation of MAPK and PI3K/AKT pathways in epithelial ovarian cancer cells. Mar Drugs. https://doi.org/10.3390/md17060331CrossRefPubMedPubMedCentral

Hashimoto T, Ozaki Y, Mizuno M et al (2012) Pharmacokinetics of fucoxanthinol in human plasma after the oral administration of kombu extract. Br J Nutr 107(11):1566–1569. https://doi.org/10.1017/s0007114511004879CrossRefPubMed

Heo YM, Kim K, Ryu SM et al (2018) Diversity and ecology of marine algicolous arthrinium species as a source of bioactive natural products. Mar Drugs. https://doi.org/10.3390/md16120508CrossRefPubMedPubMedCentral

Hitoe S, Shimoda H (2017) Seaweed fucoxanthin supplementation improves obesity parameters in mildly obese Japanese subjects. Funct Food Health Dis 7:246–262CrossRef

Huang H, Zhang G, Zhou Y et al (2018) Reverse screening methods to search for the protein targets of chemopreventive compounds. Front Chem 6:138. https://doi.org/10.3389/fchem.2018.00138CrossRefPubMedPubMedCentral

Indumathy S, Dass CR (2013) Finding chemo: the search for marine-based pharmaceutical drugs active against cancer. J Pharm Pharmacol 65(9):1280–1301. https://doi.org/10.1111/jphp.12097CrossRefPubMed

Iwamaru A, Iwado E, Kondo S et al (2007) Eupalmerin acetate, a novel anticancer agent from Caribbean gorgonian octocorals, induces apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway. Mol Cancer Ther 6(1):184–192. https://doi.org/10.1158/1535-7163.Mct-06-0422CrossRefPubMed

Jares-Erijman EA, Sakai R, Rinehart KL (1991) Crambescidins: new antiviral and cytotoxic compounds from the sponge Crambe crambe. J Org Chem 56(19):5712–5715. https://doi.org/10.1021/jo00019a049CrossRef

Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90. https://doi.org/10.3322/caac.20107CrossRef

Kalinin VI, Avilov SA, Silchenko AS et al (2015) Triterpene glycosides of sea cucumbers (Holothuroidea, Echinodermata) as taxonomic markers. Nat Prod Commun 10(1):21–26PubMed

Kashman Y, Hirsh S, McConnell OJ et al (1989) Ptilomycalin A: a novel polycyclic guanidine alkaloid of marine origin. J Am Chem Soc 111(24):8925–8926. https://doi.org/10.1021/ja00206a029CrossRef

Khalifa SAM, Elias N, Farag MA et al (2019) Marine natural products: a source of novel anticancer drugs. Mar Drugs. https://doi.org/10.3390/md17090491CrossRefPubMedPubMedCentral

Kim EJ, Lee YJ, Shin HK et al (2006) A study on the mechanism by which the aqueous extract of Inonotus obliquus induces apoptosis and inhibits proliferation in HT-29 human colon cancer cells. J Korean Soc Food Sci Nutr 35:516–523. https://doi.org/10.3746/jkfn.2006.35.5.516CrossRef

Kim SH, Shin Y, Lee SH et al (2015) Salternamides A-D from a Halophilic Streptomyces sp. Actinobacterium. J Nat Prod 78(4):836–843. https://doi.org/10.1021/acs.jnatprod.5b00002CrossRefPubMed

Kiuru P, D’Auria MV, Muller CD et al (2014) Exploring marine resources for bioactive compounds. Planta Med 80(14):1234–1246. https://doi.org/10.1055/s-0034-1383001CrossRef

Koyanagi S, Tanigawa N, Nakagawa H et al (2003) Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol 65(2):173–179. https://doi.org/10.1016/s0006-2952(02)01478-8CrossRefPubMed

Lakshmi S, Prakash P, Essa MM et al (2018) Marine derived bioactive compounds for treatment of Alzheimer’s disease. Front Biosci (Elite Ed) 10:537–548

Lee NK, Kim YH (1995) New cytotoxic anthraquinones from the crinoid Ptilometra: 1’-Deoxyrhodoptilometrin-6-O-sulfate and rhodoptilometrin-6-O-sulfate. Bull Korean Chem Soc 16(11):1011–1013

Lee S, Rauch J, Kolch W (2020) Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity. Int J Mol Sci. https://doi.org/10.3390/ijms21031102CrossRefPubMedPubMedCentral

Leisch M, Egle A, Greil R (2019) Plitidepsin: a potential new treatment for relapsed/refractory multiple myeloma. Future Oncol 15(2):109–120. https://doi.org/10.2217/fon-2018-0492CrossRefPubMed

Li B, Lu F, Wei X et al (2008) Fucoidan: structure and bioactivity. Molecules 13(8):1671–1695. https://doi.org/10.3390/molecules13081671CrossRefPubMedPubMedCentral

Li YX, Himaya SW, Dewapriya P et al (2013) Fumigaclavine C from a marine-derived fungus Aspergillus fumigatus induces apoptosis in MCF-7 breast cancer cells. Mar Drugs 11(12):5063–5086. https://doi.org/10.3390/md11125063CrossRefPubMedPubMedCentral

Lin JJ, Su JH, Tsai CC et al (2014) 11-epi-Sinulariolide acetate reduces cell migration and invasion of human hepatocellular carcinoma by reducing the activation of ERK1/2, p38MAPK and FAK/PI3K/AKT/mTOR signaling pathways. Mar Drugs 12(9):4783–4798. https://doi.org/10.3390/md12094783CrossRefPubMedPubMedCentral

Liu M, Hansen PE, Lin X (2011) Bromophenols in marine algae and their bioactivities. Mar Drugs 9(7):1273–1292. https://doi.org/10.3390/md9071273CrossRefPubMedPubMedCentral

Liu J, Ma L, Wu N et al (2014) Aplysin sensitizes cancer cells to TRAIL by suppressing P38 MAPK/survivin pathway. Mar Drugs 12(9):5072–5088. https://doi.org/10.3390/md12095072CrossRefPubMedPubMedCentral

Lv C, Sun W, Sun H et al (2013) Asperolide A, a marine-derived tetranorditerpenoid, induces G2/M arrest in human NCI-H460 lung carcinoma cells, is mediated by p53–p21 stabilization and modulated by Ras/Raf/MEK/ERK signaling pathway. Mar Drugs 11(2):316–331. https://doi.org/10.3390/md11020316CrossRefPubMedPubMedCentral

Maksimovic-Ivanic D, Stosic-Grujicic S, Nicoletti F et al (2012) Resistance to TRAIL and how to surmount it. Immunol Res 52(1–2):157–168. https://doi.org/10.1007/s12026-012-8284-8CrossRefPubMed

Malyarenko TV, Malyarenko Vishchuk OS, Ivanchina NV et al (2015) Four new sulfated polar steroids from the far eastern starfish Leptasterias ochotensis: structures and activities. Mar Drugs 13(7):4418–4435. https://doi.org/10.3390/md13074418CrossRefPubMedPubMedCentral

Marion F, Williams DE, Patrick BO et al (2006) Liphagal, a Selective inhibitor of PI3 kinase alpha isolated from the sponge akacoralliphaga: structure elucidation and biomimetic synthesis. Org Lett 8(2):321–324. https://doi.org/10.1021/ol052744tCrossRefPubMed

Martin LJ (2015) Fucoxanthin and its metabolite Fucoxanthinol in cancer prevention and treatment. Mar Drugs 13(8):4784–4798. https://doi.org/10.3390/md13084784CrossRefPubMedPubMedCentral

McClure MO, Moore JP, Blanc DF et al (1992) Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro. AIDS Res Hum Retroviruses 8(1):19–26. https://doi.org/10.1089/aid.1992.8.19CrossRefPubMed

Med PSEB (1948) Antibacterial activity of gentisyl alcohol and homogentisic acid. Proc Soc Exp Biol Med 69:201–202. https://doi.org/10.3181/00379727-69-16668CrossRef

Michel C, Lahaye M, Bonnet C et al (1996) In vitro fermentation by human faecal bacteria of total and purified dietary fibres from brown seaweeds. Br J Nutr 75(2):263–280. https://doi.org/10.1079/bjn19960129CrossRefPubMed

Munoz-Alonso MJ, Gonzalez-Santiago L, Zarich N et al (2008) Plitidepsin has a dual effect inhibiting cell cycle and inducing apoptosis via Rac1/c-Jun NH2-terminal kinase activation in human melanoma cells. J Pharmacol Exp Ther 324(3):1093–1101. https://doi.org/10.1124/jpet.107.132662CrossRefPubMed

Murakami C, Takemura M, Sugiyama Y et al (2002) Vitamin A-related compounds, all-trans retinal and retinoic acids, selectively inhibit activities of mammalian replicative DNA polymerases. Biochim Biophys Acta 1574(1):85–92. https://doi.org/10.1016/s0167-4781(01)00348-7CrossRefPubMed

Nieto M, Finn S, Loda M et al (2007) Prostate cancer: re-focusing on androgen receptor signaling. Int J Biochem Cell Biol 39(9):1562–1568. https://doi.org/10.1016/j.biocel.2007.01.005CrossRefPubMedPubMedCentral

Nishino H (1998) Cancer prevention by carotenoids. Mutat Res 402(1–2):159–163. https://doi.org/10.1016/s0027-5107(97)00293-5CrossRefPubMed

Norton R, Warren R, Wells RJTL (1977) Three new polyhalogenated monoterpenes from Plocamium species. Tetrahedron Lett 18(44):3905–3908. https://doi.org/10.1016/s0040-4039(01)83387-6CrossRef

Okuzumi J, Nishino H, Murakoshi M et al (1990) Inhibitory effects of fucoxanthin, a natural carotenoid, on N-myc expression and cell cycle progression in human malignant tumor cells. Cancer Lett 55(1):75–81. https://doi.org/10.1016/0304-3835(90)90068-9CrossRefPubMed

Oztaskin N, Cetinkaya Y, Taslimi P et al (2015) Antioxidant and acetylcholinesterase inhibition properties of novel bromophenol derivatives. Bioorg Chem 60:49–57. https://doi.org/10.1016/j.bioorg.2015.04.006CrossRefPubMed

Pan G, O’Rourke K, Chinnaiyan AM et al (1997) The receptor for the cytotoxic ligand TRAIL. Science 276(5309):111–113. https://doi.org/10.1126/science.276.5309.111CrossRefPubMed

Park HK, Kim IH, Kim J et al (2012) Induction of apoptosis by laminarin, regulating the insulin-like growth factor-IR signaling pathways in HT-29 human colon cells. Int J Mol Med 30(4):734–738. https://doi.org/10.3892/ijmm.2012.1084CrossRefPubMedPubMedCentral

Park HS, Hwang HJ, Kim GY et al (2013) Induction of apoptosis by fucoidan in human leukemia U937 cells through activation of p38 MAPK and modulation of Bcl-2 family. Mar Drugs 11(7):2347–2364. https://doi.org/10.3390/md11072347CrossRefPubMedPubMedCentral

Pearson G, Robinson F, Beers Gibson T et al (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22(2):153–183. https://doi.org/10.1210/edrv.22.2.0428CrossRefPubMed

Robert J (2013) Biology of cancer metastasis. Bull Cancer 100(4):333–342. https://doi.org/10.1684/bdc.2013.1724CrossRefPubMed

Roberts PJ, Der CJ (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26(22):3291–3310. https://doi.org/10.1038/sj.onc.1210422CrossRefPubMed

Sakai R, Rinehart KL, Kishore V et al (1996) Structure–activity relationships of the didemnins. J Med Chem 39(14):2819–2834. https://doi.org/10.1021/jm960048gCrossRefPubMed

Santarpia L, Lippman SM, El-Naggar AK (2012) Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets 16(1):103–119. https://doi.org/10.1517/14728222.2011.645805CrossRefPubMedPubMedCentral

Satomi Y, Nishino H (2009) Implication of mitogen-activated protein kinase in the induction of G1 cell cycle arrest and gadd45 expression by the carotenoid fucoxanthin in human cancer cells. Biochim Biophys Acta 1790(4):260–266. https://doi.org/10.1016/j.bbagen.2009.01.003CrossRefPubMed

Sebolt-Leopold JS (2000) Development of anticancer drugs targeting the MAP kinase pathway. Oncogene 19:6594–6599. https://doi.org/10.1038/sj.onc.1204083CrossRefPubMed

Shi D, Guo S, Jiang B et al (2013) HPN, a synthetic analogue of bromophenol from red alga Rhodomela confervoides: synthesis and anti-diabetic effects in C57BL/KsJ-db/db mice. Mar Drugs 11(2):350–362. https://doi.org/10.3390/md11020350CrossRefPubMedPubMedCentral

Shin J, Lee HS, Kim JY et al (2004) New macrolides from the sponge Chondrosia corticata. J Nat Prod 67(11):1889–1892. https://doi.org/10.1021/np040124fCrossRefPubMed

Shrestha S, Sorolla A, Fromont J et al (2018a) Crambescidin 800, isolated from the marine sponge monanchora viridis, induces cell cycle arrest and apoptosis in triple-negative breast cancer cells. Mar Drugs. https://doi.org/10.3390/md16020053CrossRefPubMedPubMedCentral

Shrestha S, Sorolla A, Fromont J et al (2018b) Aurantoside C targets and induces apoptosis in triple negative breast cancer cells. Mar Drugs. https://doi.org/10.3390/md16100361CrossRefPubMedPubMedCentral

Shubina LK, Makarieva TN, von Amsberg G et al (2019) Monanchoxymycalin C with anticancer properties, new analogue of crambescidin 800 from the marine sponge Monanchora pulchra. Nat Prod Res 33(10):1415–1422. https://doi.org/10.1080/14786419.2017.1419231CrossRefPubMed

Sun J, Shi D, Ma M et al (2005) Sesquiterpenes from the red alga Laurencia tristicha. J Nat Prod 68(6):915–919. https://doi.org/10.1021/np050096gCrossRefPubMed

Sun HF, Li XM, Meng L et al (2012) Asperolides A-C, tetranorlabdane diterpenoids from the marine alga-derived endophytic fungus Aspergillus wentii EN-48. J Nat Prod 75(2):148–152. https://doi.org/10.1021/np2006742CrossRefPubMed

Suzuki K, Mizuno R, Suenaga K et al (2013) Bisebromoamide, an extract from Lyngbya species, induces apoptosis through ERK and mTOR inhibitions in renal cancer cells. Cancer Med 2(1):32–39. https://doi.org/10.1002/cam4.53CrossRefPubMedPubMedCentral

Takaaki K, Takuya et al (2014) Biogenetically Inspired total synthesis of (+)-liphagal: a potent and selective phosphoinositide 3-Kinase α (PI3Kα) inhibitor from the Marine Sponge Aka coralliphaga. Eur J Org Chem. https://doi.org/10.1002/ejoc.201402082CrossRef

Tarhouni-Jabberi S, Zakraoui O, Ioannou E et al (2017) Mertensene, a halogenated monoterpene, induces G2/M cell cycle arrest and caspase dependent apoptosis of human colon adenocarcinoma HT29 cell line through the modulation of ERK-1/-2, AKT and NF-kappaB signaling. Mar Drugs. https://doi.org/10.3390/md15070221CrossRefPubMedPubMedCentral

Tay KC, Tan LT, Chan CK et al (2019) Formononetin: a review of its anticancer potentials and mechanisms. Front Pharmacol 10:820. https://doi.org/10.3389/fphar.2019.00820CrossRefPubMedPubMedCentral

Terasaki M, Mima M, Kudoh S et al (2018) Glycine and succinic acid are effective indicators of the suppression of epithelial-mesenchymal transition by fucoxanthinol in colorectal cancer stem-like cells. Oncol Rep 40(1):414–424. https://doi.org/10.3892/or.2018.6398CrossRefPubMed

Teruya T, Sasaki H, Fukazawa H et al (2009) Bisebromoamide, a potent cytotoxic peptide from the marine cyanobacterium Lyngbya sp.: isolation, stereostructure, and biological activity. Org Lett 11(21):5062–5065. https://doi.org/10.1021/ol9020546CrossRefPubMed

Tsai HL, Tai CJ, Huang CW et al (2017) Efficacy of low-molecular-weight fucoidan as a supplemental therapy in metastatic colorectal cancer patients: a double-blind randomized controlled trial. Mar Drugs. https://doi.org/10.3390/md15040122CrossRefPubMedPubMedCentral

Wang A, Rud J, Olson CM Jr et al (2009) Phosphorylation of Nur77 by the MEK-ERK-RSK cascade induces mitochondrial translocation and apoptosis in T cells. J Immunol 183(5):3268–3277. https://doi.org/10.4049/jimmunol.0900894CrossRefPubMed

Wang XJ, Zhang J, Wang SQ et al (2014) Identification of novel multitargeted PPARalpha/gamma/delta pan agonists by core hopping of rosiglitazone. Drug Des Devel Ther 8:2255–2262. https://doi.org/10.2147/dddt.S70383CrossRefPubMedPubMedCentral

Wang J, Gao L, Lee YM et al (2016) Target identification of natural and traditional medicines with quantitative chemical proteomics approaches. Pharmacol Ther 162:10–22. https://doi.org/10.1016/j.pharmthera.2016.01.010CrossRefPubMed

Wang LJ, Guo CL, Li XQ et al (2017) Discovery of novel bromophenol hybrids as potential anticancer agents through the ros-mediated apoptotic pathway: design, synthesis and biological evaluation. Mar Drugs. https://doi.org/10.3390/md15110343CrossRefPubMedPubMedCentral

Watjen W, Ebada SS, Bergermann A et al (2017) Cytotoxic effects of the anthraquinone derivatives 1’-deoxyrhodoptilometrin and (S)-(–)-rhodoptilometrin isolated from the marine echinoderm Comanthus sp. Arch Toxicol 91(3):1485–1495. https://doi.org/10.1007/s00204-016-1787-7CrossRefPubMed

Wen ZH, Chao CH, Wu MH et al (2010) A neuroprotective sulfone of marine origin and the in vivo anti-inflammatory activity of an analogue. Eur J Med Chem 45(12):5998–6004. https://doi.org/10.1016/j.ejmech.2010.09.067CrossRefPubMed

Williams DL (1997) Overview of (1–>3)-β-d-glucan immunobiology. Mediators Inflamm 6(4):247–250. https://doi.org/10.1080/09629359791550CrossRefPubMedPubMedCentral

Witczak ZJ, Rampulla RM, Bommareddy A (2012) Mycalamides, pederin and psymberin as natural carbohydrates and potential antitumor agents: past and future perspectives. Mini Rev Med Chem 12(14):1520–1532. https://doi.org/10.2174/138955712803832744CrossRefPubMed

Wolf D, Schmitz FJ, Qiu F et al (1999) Aurantoside C, a new tetramic acid glycoside from the sponge Homophymia conferta. J Nat Prod. https://doi.org/10.1021/np980283xCrossRefPubMed

Wright AD, Nielson JL, Tapiolas DM et al (2009) Detailed NMR, including 1,1-ADEQUATE, and anticancer studies of compounds from the echinoderm Colobometra perspinosa. Mar Dugs 7(4):565–575. https://doi.org/10.3390/md7040565CrossRef

Wu Q, Wu W, Fu B et al (2019) JNK signaling in cancer cell survival. Med Res Rev. https://doi.org/10.1002/med.21574CrossRefPubMed

Wu HL, Fu XY, Cao WQ et al (2019) Induction of apoptosis in human Glioma cells by Fucoxanthin via triggering of ROS-mediated oxidative damage and regulation of MAPKs and PI3K-AKT pathways. J Agric Food Chem 67(8):2212–2219. https://doi.org/10.1021/acs.jafc.8b07126CrossRefPubMed

Xu J, Yi M, Ding L et al (2019) A Review of anti-inflammatory compounds from marine fungi, 2000–2018. Mar Drugs 17(11):636. https://doi.org/10.3390/md17110636CrossRefPubMedCentral

Xue M, Liu Y, Lyu R et al (2017) Protective effect of aplysin on liver tissue and the gut microbiota in alcohol-fed rats. PLoS ONE 12(6):e0178684. https://doi.org/10.1371/journal.pone.0178684CrossRefPubMedPubMedCentral

Yang H, Nie Y, Li Y et al (2011) ERK1/2 deactivation enhances cytoplasmic Nur77 expression level and improves the apoptotic effect of fenretinide in human liver cancer cells. Biochem Pharmacol 81(7):910–916. https://doi.org/10.1016/j.bcp.2011.01.005CrossRefPubMedPubMedCentral

Yin F, Bruemmer D, Blaschke F et al (2004) Signaling pathways involved in induction of GADD45 gene expression and apoptosis by troglitazone in human MCF-7 breast carcinoma cells. Oncogene 23(26):4614–4623. https://doi.org/10.1038/sj.onc.1207598CrossRefPubMed

Yoshiko S, Hoyoku N (2007) Fucoxanthin, a natural carotenoid, induces G1 arrest and GADD45 gene expression in human cancer cells. Vivo 21(2):305–309

Yuan F, Qiao L, Chen Y et al (2017) AS1041, a novel synthesized derivative of marine natural compound aspergiolide A, arrests cell cycle, induces apoptosis, and inhibits ERK activation in K562 cells. Mar Drugs. https://doi.org/10.3390/md15110346CrossRefPubMedPubMedCentral

Yun SH, Park ES, Shin SW et al (2015) By activating Fas/ceramide synthase 6/p38 kinase in lipid rafts, stichoposide D inhibits growth of leukemia xenografts. Oncotarget 6(29):27596–27612. https://doi.org/10.18632/oncotarget.4820CrossRefPubMedPubMedCentral

Zhang Z, Miao L, Lv C et al (2013) Wentilactone B induces G2/M phase arrest and apoptosis via the Ras/Raf/MAPK signaling pathway in human hepatoma SMMC-7721 cells. Cell Death Dis 4:e657. https://doi.org/10.1038/cddis.2013.182CrossRefPubMedPubMedCentral

Zhang J, Liu X, Wang SQ et al (2017) Identification of dual ligands targeting angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-gamma by core hopping of telmisartan. J Biomol Struct Dyn 35(12):2665–2680. https://doi.org/10.1080/07391102.2016.1227726CrossRefPubMed

Zhou M, Peng BR, Tian W et al (2020) 12-Deacetyl-12-epi-Scalaradial, a Scalarane Sesterterpenoid from a marine sponge Hippospongia sp., induces HeLa cells apoptosis via MAPK/ERK pathway and modulates nuclear receptor Nur77. Mar Drugs. https://doi.org/10.3390/md18070375CrossRefPubMedPubMedCentral

Titel: MAPK signaling pathway-targeted marine compounds in cancer therapy
verfasst von: Jiaen Wei
Ruining Liu
Xiyun Hu
Tingen Liang
Zhiran Zhou
Zunnan Huang
Publikationsdatum: 03.01.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 1/2021
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-020-03460-y

Springer Medizin

MAPK signaling pathway-targeted marine compounds in cancer therapy

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Response rate and safety in patients with hepatocellular carcinoma treated with transarterial chemoembolization using 40-µm doxorubicin-eluting microspheres

A nanowire-based liquid biopsy method using cerebrospinal fluid cell-free DNA for targeted management of leptomeningeal carcinomatosis

Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis

Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive system

B-MYB—p53-related relevant regulator for the progression of clear cell renal cell carcinoma

MET canonical transcript expression is a predictive biomarker for chemo-sensitivity to MET-inhibitors in hepatocellular carcinoma cell lines

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie